1. Home
  2. ZURA vs SIFY Comparison

ZURA vs SIFY Comparison

Compare ZURA & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • SIFY
  • Stock Information
  • Founded
  • ZURA 2022
  • SIFY 1995
  • Country
  • ZURA United States
  • SIFY India
  • Employees
  • ZURA N/A
  • SIFY N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • SIFY Computer Software: Programming Data Processing
  • Sector
  • ZURA Health Care
  • SIFY Technology
  • Exchange
  • ZURA Nasdaq
  • SIFY Nasdaq
  • Market Cap
  • ZURA 69.9M
  • SIFY 369.1M
  • IPO Year
  • ZURA N/A
  • SIFY 1999
  • Fundamental
  • Price
  • ZURA $1.30
  • SIFY $4.87
  • Analyst Decision
  • ZURA Buy
  • SIFY
  • Analyst Count
  • ZURA 7
  • SIFY 0
  • Target Price
  • ZURA $14.33
  • SIFY N/A
  • AVG Volume (30 Days)
  • ZURA 712.2K
  • SIFY 35.2K
  • Earning Date
  • ZURA 08-08-2025
  • SIFY 07-18-2025
  • Dividend Yield
  • ZURA N/A
  • SIFY N/A
  • EPS Growth
  • ZURA N/A
  • SIFY N/A
  • EPS
  • ZURA N/A
  • SIFY N/A
  • Revenue
  • ZURA N/A
  • SIFY $466,789,000.00
  • Revenue This Year
  • ZURA N/A
  • SIFY N/A
  • Revenue Next Year
  • ZURA N/A
  • SIFY $13.46
  • P/E Ratio
  • ZURA N/A
  • SIFY N/A
  • Revenue Growth
  • ZURA N/A
  • SIFY 11.93
  • 52 Week Low
  • ZURA $0.97
  • SIFY $1.84
  • 52 Week High
  • ZURA $5.07
  • SIFY $5.71
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 58.73
  • SIFY 52.48
  • Support Level
  • ZURA $1.00
  • SIFY $4.55
  • Resistance Level
  • ZURA $1.45
  • SIFY $4.88
  • Average True Range (ATR)
  • ZURA 0.10
  • SIFY 0.20
  • MACD
  • ZURA 0.03
  • SIFY 0.03
  • Stochastic Oscillator
  • ZURA 66.67
  • SIFY 75.99

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About SIFY Sify Technologies Limited

Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.

Share on Social Networks: